Disclosed positions

Estimated from their latest filings — positions may have changed since

$3.08M

combined est. value

Stock	Shares	Price	Value	Weight	As of
VRTXVERTEX PHARMACEUTICALS INC / MA	6,624	$464.62	$3.08M	100%	2026-02-26

VRTX

VERTEX PHARMACEUTICALS INC / MA

$3.08M

6,624 sh

All filings on record

Every Form 4 transaction we track for this filer

all 12buys 0sells 5

Stock	Transaction	Date	~6mo later
VRTXVERTEX PHARMACEUTICALS INC / MA	Sell $172.6K · 357 sh	2026-02-26	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Sell $108.5K · 223 sh	2026-02-25	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Tax $264.9K · 546 sh	2026-02-24	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Sell $302.2K · 638 sh	2026-02-18	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Sell $762.1K · 1,557 sh	2026-02-17	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Tax $289.3K · 598 sh	2026-02-17	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Grant — · 1,809 sh	2026-02-17	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Tax $679.4K · 1,393 sh	2026-02-13	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Sell $633.6K · 1,376 sh	2026-02-11	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Tax $277.3K · 592 sh	2026-02-10	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Grant — · 1,300 sh	2026-01-22	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Grant — · 2,950 sh	2026-01-22	—

VRTXSell

2026-02-26 · VERTEX PHARMACEUTICALS INC / MA

$172.6K

—

VRTXSell

2026-02-25 · VERTEX PHARMACEUTICALS INC / MA

$108.5K

—

VRTXTax

2026-02-24 · VERTEX PHARMACEUTICALS INC / MA

$264.9K

—

VRTXSell

2026-02-18 · VERTEX PHARMACEUTICALS INC / MA

$302.2K

—

VRTXSell

2026-02-17 · VERTEX PHARMACEUTICALS INC / MA

$762.1K

—

VRTXTax

2026-02-17 · VERTEX PHARMACEUTICALS INC / MA

$289.3K

—

VRTXGrant

2026-02-17 · VERTEX PHARMACEUTICALS INC / MA

1,809

—

VRTXTax

2026-02-13 · VERTEX PHARMACEUTICALS INC / MA

$679.4K

—

VRTXSell

2026-02-11 · VERTEX PHARMACEUTICALS INC / MA

$633.6K

—

VRTXTax

2026-02-10 · VERTEX PHARMACEUTICALS INC / MA

$277.3K

—

VRTXGrant

2026-01-22 · VERTEX PHARMACEUTICALS INC / MA

1,300

—

VRTXGrant

2026-01-22 · VERTEX PHARMACEUTICALS INC / MA

2,950

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.